Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2014
05/20/2014US8728496 Functionalized RGD peptidomimetics and their manufacture, and implant having a coating containing such functionalized RGD peptidomimetics
05/20/2014US8728495 Methods and compositions for repair of cartilage using an in vivo bioreactor
05/20/2014US8728494 Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation
05/20/2014US8728493 Polymer based compositions and conjugates of non-steroidal anti-inflammatory drugs
05/20/2014US8728445 Hydrogel Compositions
05/20/2014US8728443 Formulation comprising nicotine and a cation exchange resin
05/20/2014US8728441 Sublingual buccal effervescent
05/20/2014US8728173 Calcium carbonate granulation
05/20/2014US8728060 Infusion device provided with a water-tight cover
05/20/2014US8728059 System and method for assuring validity of monitoring parameter in combination with a therapeutic device
05/20/2014CA2768810C Skin external-preparation composition
05/20/2014CA2656974C Thermochromic compositions for skin application
05/20/2014CA2619601C Long acting injectable parasiticidal formulations
05/20/2014CA2599585C Compositions and methods of making sustained release liquid formulations
05/20/2014CA2595615C Feminine anti-itch gel
05/20/2014CA2585116C Sustained release formulation comprising bisphosphonate
05/20/2014CA2572180C Porous tablets as carriers for liquid formulations
05/15/2014WO2014075084A2 Aqueous based capsaicinoid formulations and methods of manufacture and use
05/15/2014WO2014074997A1 Enzymes for inhibiting growth of biofilms and degrading same
05/15/2014WO2014074995A1 Enema composition for treatment of ulcerative colitis having long term stability
05/15/2014WO2014074952A1 Methods and compositions for localized delivery of agents to hiv-infected cells and tissues
05/15/2014WO2014074937A1 Free form progressive multifocal refractive lens for cataract and refractive surgery
05/15/2014WO2014074823A1 Methods and devices for the treatment of ocular diseases in human subjects
05/15/2014WO2014074808A1 Pharmaceutical core-shell composite powder and processes for making the same
05/15/2014WO2014074806A1 Improved reattachment of detached cartilage to subchondral bone
05/15/2014WO2014074797A1 Ultra low density pulmonary powders
05/15/2014WO2014074795A1 High dose levodopa capsules for pulmonary use
05/15/2014WO2014074749A1 Gras enteric coating formulations and methods of making and using same
05/15/2014WO2014074289A1 Delivery of biologically-active agents using volatile, hydrophobic solvents
05/15/2014WO2014074226A1 No comprising compositions and methods for treatment of osteoporosis
05/15/2014WO2014074225A1 Bioglass with glycosaminoglycans
05/15/2014WO2014074114A1 Drying methods for tuning microparticle properties
05/15/2014WO2014074017A1 New medicinal composition for pain management in the case of smooth muscle spasm
05/15/2014WO2014074007A1 Dermatological composition with indicator properties
05/15/2014WO2014073842A1 Liquid formulation of protein conjugate comprising the oxyntomodulin and an immunoglobulin fragment
05/15/2014WO2014073698A1 Nystose crystal-containing powder
05/15/2014WO2014073675A1 Thick liquid diet
05/15/2014WO2014072747A1 Dermal compositions containing unnatural hygroscopic amino acids
05/15/2014WO2014072647A1 Co-micronisation product comprising a selective progesterone-receptor modulator
05/15/2014WO2014072646A1 Co-micronisation product comprising ulipristal acetate
05/15/2014WO2014072468A1 Compositions for pulmonary delivery
05/15/2014WO2014072346A1 Immediate release formulations of cinacalcet
05/15/2014WO2014072259A1 Composition
05/15/2014WO2014072015A1 Use of silicon oxide-based material for the modified release of biologically active agents
05/15/2014WO2014071757A1 Sevelamer carbonate medicinal tablet composition and preparation method thereof
05/15/2014WO2014071499A1 Pharmaceutical compositions comprising hydromorphone and naloxone
05/15/2014WO2014047191A4 Transdermal drug delivery device
05/15/2014WO2014030995A3 Encapsulation system
05/15/2014WO2014027979A3 Tablet formulations comprising tadalafil and dapoxetine
05/15/2014WO2013152059A8 Multicolored ph-activatable fluorescence nanoplatform
05/15/2014US20140135743 System and Method for Correction of Intracerebral Chemical Imbalances
05/15/2014US20140135712 Visual Indication of Rupture of Drug Reservoir
05/15/2014US20140135684 Long term drug delivery devices with polyurethane based polymers and their manufacture
05/15/2014US20140135395 Gastric retentive gabapentin dosage forms and methods for using same
05/15/2014US20140135388 Self-Emulsifying Active Ingredient Formulation and the Use of This Formulation
05/15/2014US20140135386 Method for treating atherosclerosis or restenosis using microtubule stabilizing agent
05/15/2014US20140135379 Method of fixing and expressing physiologically active substance
05/15/2014US20140135376 Nanogels
05/15/2014US20140135355 Abuse-Resistant Controlled-Release Opioid Dosage Form
05/15/2014US20140135352 Tablet having improved elution properties
05/15/2014US20140135350 Sustained-release dosage forms of ruxolitinib
05/15/2014US20140135340 High Drug Load Tablet
05/15/2014US20140135303 Hazardous Agent Injection System
05/15/2014US20140135285 Devices and methods for inhibiting adhesion formation
05/15/2014US20140135263 Rapid Acting Injectable Insulin Compositions
05/15/2014US20140135230 Lipoparticles Comprising Proteins, Methods Of Making, And Using The Same
05/15/2014US20140134320 Method and system for printing personalized medication
05/15/2014US20140134259 Stable oral benzimidazole compositions and process of preparation thereof
05/15/2014US20140134258 Implants for "load bearing" bone substitutions having hierarchical organized architecture deriving from transformation of vegetal structures
05/15/2014US20140134256 Drug Microparticles
05/15/2014US20140134253 Dry powder fosfomycin/tobramycin formulation for inhalation
05/15/2014US20140134252 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
05/15/2014US20140134251 Pharmaceutical formulations and methods for treating respiratory tract infections
05/15/2014US20140134250 Oxymorphone controlled release formulations
05/15/2014US20140134248 Pharmaceutical compositions
05/15/2014US20140134247 Pharmaceutical composition
05/15/2014US20140134246 Rapid dissolve tablet compositions for vaginal administration
05/15/2014US20140134245 Ibuprofen chewable tablet
05/15/2014US20140134244 Antifungal compositions with improved bioavailability
05/15/2014US20140134243 Compositions for the Treatment of CNS-Related Conditions
05/15/2014US20140134240 pH INDUCED SILK GELS AND USES THEREOF
05/15/2014US20140134239 Compositions and methods for treatment of the side-effects associated with administration of cancer chemotherapeutic agents
05/15/2014US20140134234 Gene or drug delivery system
05/15/2014US20140134232 Encapsulation of Plasmid DNA (Lipogenes™) and Therapeutic Agents with Nuclear Localization Signal/Fusogenic Peptide Conjugates into Targeted Liposome Complexes
05/15/2014US20140134230 Transdermal therapeutic system
05/15/2014US20140134228 Chewable wafers containing lipid supplements for maintaining health and the treatment of acute and chronic disorders
05/15/2014US20140134226 Compositions and methods for inhibiting bone growth
05/15/2014US20140134211 Formulations and Methods for Recovery From Dental Surgery
05/15/2014US20140134150 Technology for preparation of macromolecular microspheres
05/15/2014US20140134113 Pharmaceutical compositions
05/15/2014US20140134112 Topical Pharmaceutical Foam Composition
05/15/2014US20140134106 Pharmaceutical composition of oxidised avidin suitable for inhalation
05/14/2014EP2730604A2 Functionalized caprolactone monomers useful for making poly(ethylene oxide)-block-poly(ester) block copolymers
05/14/2014EP2730292A1 Aqueous ophthalmic composition
05/14/2014EP2730290A1 Adhesive skin patch containing serotonin receptor antagonist drug
05/14/2014EP2730280A1 A pharmaceutical composition comprising a menthane carboxylic acid amide
05/14/2014EP2730279A1 Immediate release formulations of cinacalcet
05/14/2014EP2730278A1 Composition melt
05/14/2014EP2730277A2 Drug carrier and drug carrier kit for inhibiting fibrosis
05/14/2014EP2730274A2 Instant powders for aqueous cosmetic and pharmaceutical applications
1 ... 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 ... 2991